Michael A Stellon1, Kelsey Cobourn1, Matthew T Whitehead2, Nancy Elling3, William McClintock3, Chima O Oluigbo4. 1. Department of Neurosurgery, Children's National Medical Center, Washington, DC, USA. 2. Department of Imaging and Diagnostic Radiology, Children's National Medical Center, Washington, DC, USA. 3. Tuberous Sclerosis Clinic, Department of Neurology, Children's National Medical Center, Washington, DC, USA. 4. Department of Neurosurgery, Children's National Medical Center, Washington, DC, USA. coluigbo@cnmc.org.
Abstract
PURPOSE: Tuberous sclerosis (TSC) is a well-known cause of medically refractory epilepsy (MRE). Stereoencephalography-directed magnetic resonance-guided laser interstitial thermal therapy (SEEG-directed MRgLITT) is an emerging minimally invasive technique that appears aptly suited for the surgical management of TSC. Our aims are to present our experiences with patients who had undergone SEEG-directed MRgLITT to identify and treat cortical tubers responsible for clinical seizures and to perform an in-depth analysis of volumetric and thermal dynamic factors that may be related to seizure outcomes. METHODS: We studied all pediatric patients with MRE due to TSC who underwent SEEG-directed MRgLITT, investigating seizure outcomes in relation to thermal dynamic and volumetric factors. RESULTS: Eight cortical tubers from three pediatric patients were analyzed. Two of three patients had Engel I outcomes at last follow-up (median 18 months). Average A/T (ablation volume/tuber volume) ratio for Engel I outcomes was 1.28 (variance, 0.16) and 0.84 (variance, < 0.01) for all other outcomes (P = 0.035). There was a moderate positive correlation when comparing ablation energy to ablation volume (R2 = 0.65) in cortical tuber tissue. When the calcified tuber is excluded, the correlation is stronger (R2 = 0.77). Thus, the calculated energy needed to ablate 1 cm3 of cortical tuber tissue is 1263.6 J (calcified tuber) or 1089.5 J (non-calcified tuber). CONCLUSIONS: SEEG-directed MRgLITT appears to be a safe and effective technique in the management of pediatric patients with MRE due to TSC. The A/T ratio may be a useful indicator in predicting seizure outcomes.
PURPOSE:Tuberous sclerosis (TSC) is a well-known cause of medically refractory epilepsy (MRE). Stereoencephalography-directed magnetic resonance-guided laser interstitial thermal therapy (SEEG-directed MRgLITT) is an emerging minimally invasive technique that appears aptly suited for the surgical management of TSC. Our aims are to present our experiences with patients who had undergone SEEG-directed MRgLITT to identify and treat cortical tubers responsible for clinical seizures and to perform an in-depth analysis of volumetric and thermal dynamic factors that may be related to seizure outcomes. METHODS: We studied all pediatric patients with MRE due to TSC who underwent SEEG-directed MRgLITT, investigating seizure outcomes in relation to thermal dynamic and volumetric factors. RESULTS: Eight cortical tubers from three pediatric patients were analyzed. Two of three patients had Engel I outcomes at last follow-up (median 18 months). Average A/T (ablation volume/tuber volume) ratio for Engel I outcomes was 1.28 (variance, 0.16) and 0.84 (variance, < 0.01) for all other outcomes (P = 0.035). There was a moderate positive correlation when comparing ablation energy to ablation volume (R2 = 0.65) in cortical tuber tissue. When the calcified tuber is excluded, the correlation is stronger (R2 = 0.77). Thus, the calculated energy needed to ablate 1 cm3 of cortical tuber tissue is 1263.6 J (calcified tuber) or 1089.5 J (non-calcified tuber). CONCLUSIONS: SEEG-directed MRgLITT appears to be a safe and effective technique in the management of pediatric patients with MRE due to TSC. The A/T ratio may be a useful indicator in predicting seizure outcomes.
Entities:
Keywords:
MIES, stereotactic electroencephalography; MRgLITT; SEEG, magnetic resonance guided laser interstitial thermal therapy; TSC, minimally invasive epilepsy surgery; Tuberous sclerosis
Authors: Roman Liscak; Hana Malikova; Miroslav Kalina; Zdenek Vojtech; Tomas Prochazka; Petr Marusic; Vilibald Vladyka Journal: Acta Neurochir (Wien) Date: 2010-04-02 Impact factor: 2.216
Authors: Jonathan Roth; Adeolu Olasunkanmi; Tracy S Ma; Chad Carlson; Orrin Devinsky; David H Harter; Howard L Weiner Journal: Epilepsia Date: 2012-01-13 Impact factor: 5.864
Authors: Tracy S Ma; Robert E Elliott; Véronique Ruppe; Orrin Devinsky; Ruben Kuzniecky; Howard L Weiner; Chad Carlson Journal: J Neurosurg Pediatr Date: 2012-09-21 Impact factor: 2.375
Authors: Patrick Kwan; Alexis Arzimanoglou; Anne T Berg; Martin J Brodie; W Allen Hauser; Gary Mathern; Solomon L Moshé; Emilio Perucca; Samuel Wiebe; Jacqueline French Journal: Epilepsia Date: 2009-11-03 Impact factor: 5.864
Authors: Jean Régis; Marc Rey; Fabrice Bartolomei; Vilibald Vladyka; Roman Liscak; Oskar Schröttner; Gerhard Pendl Journal: Epilepsia Date: 2004-05 Impact factor: 5.864
Authors: Catherine J Chu-Shore; Philippe Major; Susana Camposano; David Muzykewicz; Elizabeth A Thiele Journal: Epilepsia Date: 2009-12-22 Impact factor: 5.864